XML 112 R63.htm IDEA: XBRL DOCUMENT v3.21.1
Business Combinations - Summary of Fair Values of Identifiable Net Assets (Details) - EUR (€)
€ in Thousands
Oct. 31, 2020
May 06, 2020
Jan. 06, 2020
Dec. 31, 2019
Lipocalyx GmbH        
Assets        
Goodwill       € 896
Intangible assets       5,978
Property, plant and equipment       75
Inventories       139
Liabilities        
Consideration transferred       7,088
Consideration        
Cash paid     € 6,500 6,516
Contingent consideration liability     € 600 572
Total consideration       € 7,088
BioNTech US Inc.        
Assets        
Goodwill   € 56,573    
Intangible assets   29,867    
Property, plant and equipment   5,617    
Right-of-use assets   6,896    
Other assets non-current and current   2,704    
Cash and cash equivalents   7,749    
Total Assets   52,833    
Liabilities        
Trade payables   1,723    
Other liabilities non-current and current   17,793    
Total liabilities   19,516    
Total identifiable net assets at fair value   33,317    
Consideration transferred   89,890    
Consideration        
Shares issued, at fair value   89,548    
Cash paid   342    
Total consideration   € 89,890    
BioNTech Manufacturing Marburg GmbH        
Assets        
Property, plant and equipment € 79,828      
Right-of-use assets 28,514      
Inventories 2,466      
Other assets non-current and current 4,343      
Cash and cash equivalents 16,319      
Total Assets 131,470      
Liabilities        
Provisions non-current and current 5,127      
Trade payables 8,105      
Other liabilities non-current and current 33,383      
Total liabilities 46,615      
Total identifiable net assets at fair value 84,855      
Bargain purchase (7,002)      
Consideration transferred 77,853      
Consideration        
Cash paid 77,853      
Total consideration € 77,853